Immune Control's Merger

Immune Control raised a round of funding on June 17, 2010. Investors include Corridor Pharmaceuticals.

Immune Control is an early-stage drug discovery company that has developed novel approaches to immune modulation using small molecule, serotonin antagonists. Merged with Arginetix to form Corridor …

Articles about Immune Control's Merger: